Abrdn Life Sciences Investors Fund (HQL)
Abrdn Life Sciences Investors Fund (HQL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2017 | 09-2011 | 09-2007 | 09-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | N/A | N/A | 1 | 1 |
| Receivables | N/A | N/A | 10 | 1,370 |
| Other current assets | 0 | 0 | 289 | 49 |
| TOTAL | $N/A | $N/A | $300 | $1,420 |
| Non-Current Assets | ||||
| Investments And Advances | 0 | 0 | 308,770 | 269,390 |
| TOTAL | $N/A | $N/A | $308,770 | $269,390 |
| Total Assets | $N/A | $N/A | $309,070 | $270,810 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accrued Expenses | N/A | N/A | 510 | 630 |
| TOTAL | $N/A | $N/A | $510 | $630 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 0 | 560 | 2,050 |
| TOTAL | $N/A | $N/A | $560 | $2,050 |
| Total Liabilities | $N/A | $N/A | $1,080 | $2,690 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | N/A | 14,578 | N/A | N/A |
| Retained earnings | N/A | N/A | -1,320 | 0 |
| Other shareholders' equity | 0 | 0 | 309,310 | 268,110 |
| TOTAL | $N/A | $N/A | $307,990 | $268,110 |
| Total Liabilities And Equity | $0 | $0 | $309,070 | $270,800 |